Position in IQV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,483,070
+$700,586 QoQ
Shares Held
12,851
+23.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#396
of 1,082 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Stamos Capital Partners, L.P. holds $5,490,728 across 2 Diagnostics & Research names. IQV ranks #2 (45.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,999 | $3,007,658 | |
| 2 | IQV |
Iqvia Holdings Inc.
This page
|
12,851 | $2,483,070 |
All Filings in IQV
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,483,070 | 12,851 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,782,484 | 10,452 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,682,460 | 7,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,277,536 | 6,726 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,332,738 | 8,457 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,003,323 | 5,691 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,489,545 | 7,580 | Shares | Sole | 2025-02-13 | |
| 2023-09-30 | $2,038,330 | 10,360 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $2,328,617 | 10,360 | Shares | Sole | 2023-08-11 | |
| 2022-09-30 | $485,455 | 2,680 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $442,659 | 2,040 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $471,668 | 2,040 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||